Collegium Pharmaceutical, Inc. (COLL) vs Evotec AG (EVO)
- Collegium Pharmaceutical, Inc. COLL 23.19 +0.04%
- Evotec AG EVO 1.38 −2.82%
Collegium Pharmaceutical, Inc. and Evotec AG are both Drug Manufacturers Specialty & Generic companies. Collegium Pharmaceutical, Inc. is the larger, with a market value of $754.6M against $504.4M — 1.5× the size. Evotec AG has negative trailing earnings, so its P/E is not meaningful; Collegium Pharmaceutical, Inc. trades at 15.2×. Collegium Pharmaceutical, Inc. grew revenue faster over the last twelve months: 14.3% against 2.15%. Collegium Pharmaceutical, Inc. has the higher net margin (5.93% vs −26.2%) and the higher return on invested capital (7.85% vs 0.00%). Across the 19 metrics below, Collegium Pharmaceutical, Inc. leads on 12 and Evotec AG on 7.
Valuation
Profitability
| Metric | COLL | EVO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 60.02% | 11.42% | 53.94% |
| Operating margin | 19.48% | (21.35%) | 0.00% |
| Net margin | 5.93% | (26.20%) | 0.00% |
| Free cash flow margin | 40.62% | 0.00% | 0.00% |
| Return on equity | 17.61% | 0.00% | (0.40%) |
| Return on assets | 2.57% | 0.00% | (3.32%) |
| Return on invested capital | 7.85% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack